Massachusetts Group Insurance Commission Faces $240M Funding Gap
Massachusetts Group Insurance Commission seeks $240M to cover health claims deficit driven by rising provider prices and prescription drug utilization, including GLP-1 medications.
President Trump's Executive Order Aims to Lower Drug Prices by Aligning Small Molecule Drug Policy with Biologics
President Trump's latest executive order modifies the Medicare Drug Price Negotiation Program, aligning the treatment of small molecule drugs with biologics and aiming to reduce drug prices.
Congress Calls for GAO Probe into Medicare Advantage Plan Acquisitions
U.S. Representatives urge a probe into Medicare Advantage plans acquiring health businesses, potentially affecting compliance with medical loss ratio standards.
SSA Enhances Telephone Claim Security with New Anti-Fraud Technology
The Social Security Administration enhances security and accessibility for telephone claims with new anti-fraud technology. Learn how this impacts beneficiaries and prevents fraud.
Tackling Medicare Fraud: A Call for Reform and Efficiency
Explore the urgent need for reforms in Medicare to combat fraud, which costs taxpayers billions yearly.